转录因子PITX2保护肠道上皮细胞免受炎症应激:对于性结肠炎的影响直肠偏好和治疗耐药性
Hirosumi Suzuki1, Xiangning Guo1, Taku Sawafuji1
1Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan; Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
Biochemical and biophysical research communications
|January 24, 2026
概括
转录因子PITX2在炎症期间保护肠道细胞免受亡. 它在直肠中的较低水平可能解释了为什么性结肠炎 (UC) 在直肠开始并抵抗治疗.
科学领域:
- 胃肠病学 胃肠病学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 性结肠炎 (UC),一种炎症性肠病 (IBD),通常会影响结肠,通常从直肠开始.
- 在UC中直肠偏好和治疗抵抗的原因尚未完全理解.
- 在直肠和结肠组织之间肠上皮细胞 (IEC) 的差异可能在UC病变发生中起作用.
研究的目的:
- 调查直肠和上升结肠之间的IEC差异在UC中的作用.
- 确定有助于UC局部化和治疗耐药性的分子机制.
主要方法:
- 对患者匹配的结肠器官的基因表达分析.
- 在非损伤的上升结肠器官中,PITX2 (转录因子) 被确定为升高.
- 在炎症条件下PITX2操纵后,评估IEC扩散,亡和炎症信号的功能测试.
主要成果:
- 发现PITX2在与直肠相比,来自非损伤的上升结肠的器官中升高.
- 在IEC中抑制PITX2显著增加了亡,并在炎症刺激下减少了增殖和球体形成.
- 这种效应独立于NF-κB信号传递或ROS产生,这表明它在细胞存活中发挥了直接作用.
结论:
- 在IEC中,PITX2通过在炎症性压力期间促进生存和抑制亡,起到保护作用.
- 在直肠组织中较低的PITX2水平可能会导致直肠对UC发作的敏感性及其对治疗的抵抗性.
- 在IBD中,PITX2是调节结肠上皮质防御的潜在治疗标.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
943
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
943
Transcription Factors
82.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Transcription Elongation Factors
13.5K
Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
13.5K
Transcription Elongation Factors
4.6K
4.6K
Drugs for Treatment of Ulcerative Colitis in IBD
482
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
482
General Transcription Factors
6.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.8K


